603880 Jiangsu Nanfang Medical
- 5.04
- +0.11+2.23%
Jiangsu Nanfang Medical News
Announcement of Nanwei Co., Ltd. on the controlling shareholder and senior management receiving the notice of filing a case from the China Securities Regulatory Commission
Announcement of Nawi Shares on Completion of Industrial and Commercial Change Registration and Issuance of Business License.
Announcement on the Progress of Nanwei Stock Co., Ltd.'s Wholly-owned Subsidiary Providing Guarantee for the Company
Announcement on Revocation of Other Risk Warnings and Suspension by Nanwei Co., Ltd.
Announcement from Nanwei Stock on the application for removal of other risk warnings for the company's stocks.
Announcement of Nanwei Co., Ltd. on holding a briefing on the 2023 annual results and cash dividends
Nanwei Co., Ltd.'s progress announcement on matters relating to the implementation of other risk warnings for stocks
Announcement of Nanwei Co., Ltd. in response to the Shanghai Stock Exchange's 2023 Annual Report Information Disclosure Regulatory Inquiry Letter
Announcement of Nanwei Co., Ltd. on further postponing the response to the Shanghai Stock Exchange's regulatory inquiry letter on the disclosure of information disclosure in the company's 2023 annual report
Announcement of the results of the lawsuit involving Nanwei Co., Ltd.
Announcement of Nanwei Co., Ltd. on postponing the response to the Shanghai Stock Exchange's inquiry letter on the disclosure of information disclosure in the company's 2023 annual report
Nanwei Co., Ltd.'s progress announcement on matters relating to the implementation of other risk warnings for stocks
Announcement of resolutions of the 2023 Annual General Meeting of Shareholders of Nanwei Co., Ltd
Legal Opinion of the 2023 Annual General Meeting of Shareholders of Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd.
Materials of the 2023 Annual General Meeting of Shareholders of Nanwei Co., Ltd.
Nanwei Co., Ltd. 2023 Internal Control Evaluation Report
Nanwei Co., Ltd. 2023 Board Audit Committee Performance Report
Report on the performance of supervisory duties of accounting firms by the Audit Committee of Nanwei Co., Ltd. in 2023
Special report by the board of directors of Nanwei Co., Ltd. on the self-inspection of the independence of independent directors
Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. shareholder return plan for the next three years (2024-2026)
No Data
